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Table S1. Spearman correlation coefficients for prenatal plasma PFAS concentrations in 
children who had an early childhood assessment (n = 1,006). 
Chemical PFOS PFOA PFHxS PFNA 
PFOS 1.00    
PFOA 0.74 1.00   
PFHxS 0.50 0.53 1.00  
PFNA 0.62 0.55 0.44 1.00 
PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, 
perfluorooctanoate; PFOS, perfluorooctane sulfonate. 




Table S2. Spearman correlation coefficients for adiposity measurements collected in mid-childhood (n = 693). 
Measurement 
























DXA trunk fat 
mass index 
(kg/m2) 
Overall adiposity           
BMI (kg/m2) 1.00          
BMI z-score 0.98 1.00         
Sum of subscapular and 
triceps skinfold thickness 
(mm) 
0.80 0.78 1.00        
DXA total fat mass index 
(kg/m2) 
0.81 0.80 0.90 1.00       
DXA total fat-free mass 
index (kg/m2) 
0.78 0.77 0.41 0.37 1.00      
           
Central adiposity           
Waist circumference (cm) 0.86 0.83 0.73 0.73 0.66  1.00    
Waist-to-hip 
circumference ratio 
0.26 0.28 0.19 0.23 0.20  0.50 1.00   
Subscapular-to-triceps 
skinfold thickness ratio 
0.20 0.19 0.12 0.10 0.23  0.21 0.18 1.00  
DXA trunk fat mass index 
(kg/m2) 
0.78 0.77 0.89 0.98 0.35  0.72 0.25 0.13 1.00 
BMI, body mass index; DXA, dual X-ray absorptiometry. 
*All coefficients significant at a p-value of <0.01. 
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Table S3. Associations of prenatal plasma PFAS concentrations with overweight and obesity in early and 
mid-childhood among all children and stratified by child sex.a,b,c 
 All children Boys Girls  
pintRRR (95% CI) RRR (95% CI) RRR (95% CI)  
Early childhood     
Overweight (85th-<95th vs. <85th)    
PFOS 1.07 (0.92, 1.24) 1.04 (0.82, 1.31) 1.11 (0.90, 1.36)  0.36
PFOA 1.05 (0.87, 1.26) 0.96 (0.70, 1.31) 1.10 (0.88, 1.38)  0.33
PFHxS 1.03 (0.94, 1.13) 1.02 (0.88, 1.17) 1.05 (0.93, 1.18)  0.73
PFNA 1.12 (0.96, 1.30) 1.03 (0.81, 1.30) 1.20 (0.97, 1.49)  0.24
Obese (≥95th vs. <85th)      
PFOS 0.97 (0.76, 1.23) 0.95 (0.68, 1.32) 0.96 (0.65, 1.43)  0.75
PFOA 1.03 (0.80, 1.32) 0.98 (0.67, 1.45) 1.05 (0.72, 1.52)  0.75
PFHxS 1.02 (0.89, 1.17) 0.94 (0.75, 1.17) 1.07 (0.90, 1.26)  0.43
PFNA 0.97 (0.75, 1.27) 0.85 (0.59, 1.23) 1.03 (0.69, 1.55)  0.46
        
Mid-childhood      
Overweight (85th-<95th vs. <85th)      
PFOS 1.15 (0.95, 1.40) 1.20 (0.92, 1.57) 1.08 (0.80, 1.46)  0.63
PFOA 1.02 (0.80, 1.29) 0.94 (0.64, 1.40) 1.06 (0.78, 1.44)  0.36
PFHxS 1.04 (0.92, 1.17) 0.95 (0.77, 1.19) 1.11 (0.95, 1.29)  0.16
PFNA 1.06 (0.85, 1.32) 1.11 (0.83, 1.48) 0.99 (0.67, 1.46)  0.64
Obese (≥95th vs. <85th)      
PFOS 1.12 (0.90, 1.38) 1.02 (0.73, 1.42) 1.20 (0.90, 1.60)  0.86
PFOA 1.10 (0.88, 1.37) 0.97 (0.64, 1.48) 1.15 (0.88, 1.51)  0.73
PFHxS 1.07 (0.94, 1.22) 0.91 (0.70, 1.18) 1.14 (0.97, 1.33)  0.22
PFNA 1.21 (0.99, 1.47) 1.12 (0.78, 1.60) 1.31 (1.00, 1.70)  0.81
PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, 
perfluorooctane sulfonate. 
aEffect estimates represent the risk of overweight (BMI ≥85th and <95th percentile) or obesity (BMI ≥95th percentile) relative to 
underweight/normal weight (BMI <85th percentile) for a change in PFAS concentrations from the 25th to the 75th percentile (or 
interquartile range). 
bModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, and 
child sex, child’s age at outcome assessment. 
cChildren at early childhood visit = overweight: 188 (103 boys and 85 girls) and obese: 93 (59 boys and 34 girls); mid-childhood visit = 






















Figure S1. Mean change (+ 95% confidence intervals) in mid-childhood adiposity 
measurements associated with an IQR increment in prenatal plasma PFOA concentrations. 
Models adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing 
of blood draw, household income, child sex and age at outcome assessment. Subscapular-to-
triceps skinfold thickness ratio was multiplied by 100 to make estimate interpretable. 
Abbreviations: BMI, body mass index; DXA, dual X-ray absorptiometry, IQR, interquartile 











Mid-childhood adiposity measurements 
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 pint = 0.20                pint = 0.30           pint = 0.31           pint = 0.19           pint = 0.08 
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Table S4. Associations of prenatal plasma PFAS concentrations with overall and central adiposity 
measurements in early childhood among all children and stratified by child sex (models adjusted for 
all PFAS simultaneously).a,b,c 
 All children Boys Girls 
β (95% CI) β (95% CI) β (95% CI) 
Overall adiposity    
BMI (kg/m2)   
PFOS -0.02 (-0.14, 0.11)  0.00 (-0.17, 0.18)  -0.03 (-0.21, 0.14) 
PFOA 0.10 (-0.04, 0.24)  0.14 (-0.09, 0.37)  0.08 (-0.11, 0.26) 
PFHxS 0.00 (-0.06, 0.05)  -0.01 (-0.10, 0.08)  0.00 (-0.07, 0.08) 
PFNA 0.00 (-0.10, 0.10)  -0.10 (-0.25, 0.06)  0.06 (-0.08, 0.21) 
BMI z-score      
PFOS 0.01 (-0.08, 0.09)  0.02 (-0.10, 0.14)  0.00 (-0.12, 0.12) 
PFOA 0.04 (-0.05, 0.14)  0.04 (-0.12, 0.20)  0.04 (-0.08, 0.17) 
PFHxS 0.00 (-0.04, 0.04)  0.01 (-0.05, 0.07)  0.00 (-0.05, 0.05) 
PFNA 0.00 (-0.08, 0.07)  -0.06 (-0.17, 0.05)  0.03 (-0.06, 0.13) 
Sum of subscapular and triceps 






PFOS -0.41 (-0.77, -0.05)  -0.48 (-0.97, 0.01)  -0.31 (-0.83, 0.21) 
PFOA 0.42 (0.02, 0.83)  0.95 (0.29, 1.60)  0.11 (-0.44, 0.65) 
PFHxS 0.18 (0.02, 0.35)  0.14 (-0.11, 0.40)  0.19 (-0.02, 0.41) 
PFNA -0.03 (-0.33, 0.28)  -0.41 (-0.86, 0.04)  0.23 (-0.20, 0.65) 
      
Central adiposity    
Waist circumference (cm)    
PFOS -0.17 (-0.47, 0.14)  -0.28 (-0.72, 0.15)  -0.04 (-0.48, 0.39) 
PFOA 0.47 (0.12, 0.82)  0.98 (0.40, 1.56)  0.13 (-0.32, 0.58) 
PFHxS 0.01 (-0.13, 0.15)  -0.04 (-0.26, 0.18)  0.03 (-0.15, 0.20) 
PFNA -0.09 (-0.35, 0.16)  -0.37 (-0.76, 0.02)  0.09 (-0.26, 0.43) 
Waist-to-hip circumference ratiod    
PFOS -0.24 (-0.72, 0.25) -0.76 (-1.47, -0.05) 0.28 (-0.38, 0.93) 
PFOA 0.27 (-0.28, 0.82) 0.84 (-0.09, 1.78) -0.21 (-0.88, 0.46) 
PFHxS -0.03 (-0.25, 0.19) 0.03 (-0.33, 0.39) -0.10 (-0.37, 0.17) 








PFOS -0.16 (-1.49, 1.17) 0.74 (-1.01, 2.49) -1.21 (-3.26, 0.84) 
PFOA 0.58 (-0.94, 2.09) -0.38 (-2.69, 1.94) 1.60 (-0.53, 3.72) 
PFHxS -0.23 (-0.83, 0.38) -0.50 (-1.39, 0.39) 0.01 (-0.84, 0.86) 
PFNA 0.46 (-0.68, 1.59) 0.48 (-1.10, 2.07) 0.50 (-1.17, 2.17) 
BMI, body mass index; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; 
PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate. 
aEffect estimates represent the mean change in the outcome for a change in PFAS concentrations from the 25th to the 75th 
percentile (or interquartile range). 
bModels adjusted for all four PFAS, maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of sample 
collection, household income, child sex and age at outcome assessment. 
cChildren with data on BMI and BMI z-score: 988 (522 boys and 466 girls); sum of subscapular and triceps skinfold thickness 
and subscapular-to-triceps skinfold thickness ratio: 964 (509 boys and 455 girls); waist circumference: 992 (521 boys and 471 
girls); and waist-to-hip circumference ratio: 987 (519 boys and 468 girls). 




Table S5. Associations of prenatal plasma PFAS concentrations with overall and central adiposity 
measurements in mid-childhood among all children and stratified by child sex (models adjusted for 
all PFAS simultaneously).a,b,c 
 All children Boys Girls 
β (95% CI) β (95% CI) β (95% CI) 
Overall adiposity    
BMI (kg/m2)    
PFOS 0.09 (-0.19, 0.36) 0.02 (-0.37, 0.42) 0.12 (-0.27, 0.51) 
PFOA 0.01 (-0.28, 0.30) -0.06 (-0.55, 0.45) 0.03 (-0.33, 0.39) 
PFHxS 0.01 (-0.12, 0.14) -0.07 (-0.29, 0.15) 0.06 (-0.10, 0.22) 
PFNA 0.12 (-0.10, 0.34) 0.04 (-0.32, 0.40) 0.22 (-0.06, 0.51) 
BMI z-score    
PFOS 0.06 (-0.03, 0.16) 0.08 (-0.05, 0.20) 0.04 (-0.10, 0.17) 
PFOA -0.01 (-0.11, 0.09) -0.11 (-0.27, 0.05) 0.05 (-0.08, 0.17) 
PFHxS -0.01 (-0.05, 0.04) -0.01 (-0.08, 0.06) 0.00 (-0.06, 0.05) 
PFNA 0.02 (-0.05, 0.09) 0.02 (-0.10, 0.13) 0.04 (-0.06, 0.14) 
Sum of subscapular and triceps 
skinfold thickness (mm)    
PFOS 0.06 (-0.81, 0.94) 0.19 (-0.97, 1.35) -0.15 (-1.49, 1.19) 
PFOA 0.16 (-0.77, 1.08) -0.20 (-1.66, 1.26) 0.42 (-0.84, 1.67) 
PFHxS 0.15 (-0.26, 0.56) -0.28 (-0.91, 0.36) 0.45 (-0.11, 1.00) 
PFNA 0.48 (-0.22, 1.18) 0.21 (-0.84, 1.27) 0.81 (-0.17, 1.78) 
DXA total fat mass index (kg/m2)    
PFOS 0.05 (-0.14, 0.24) 0.04 (-0.22, 0.30) 0.04 (-0.23, 0.32) 
PFOA 0.08 (-0.12, 0.28) 0.11 (-0.24, 0.46) 0.08 (-0.17, 0.34) 
PFHxS 0.02 (-0.06, 0.11) -0.06 (-0.20, 0.08) 0.06 (-0.05, 0.17) 
PFNA 0.01 (-0.16, 0.18) -0.07 (-0.30, 0.16) 0.12 (-0.14, 0.38) 
DXA total fat-free mass index 
(kg/m2)    
PFOS 0.07 (-0.06, 0.20) 0.03 (-0.15, 0.21) 0.11 (-0.09, 0.30) 
PFOA 0.00 (-0.14, 0.14) -0.02 (-0.26, 0.23) 0.00 (-0.18, 0.18) 
PFHxS -0.01 (-0.07, 0.05) -0.04 (-0.14, 0.06) 0.00 (-0.08, 0.08) 
PFNA 0.05 (-0.06, 0.17) 0.09 (-0.07, 0.25) -0.01 (-0.19, 0.18) 
      
Central adiposity    
Waist circumference (cm)    
PFOS 0.27 (-0.47, 1.00) 0.14 (-0.87, 1.14) 0.31 (-0.78, 1.40) 
PFOA -0.09 (-0.86, 0.68) -0.49 (-1.76, 0.77) 0.09 (-0.92, 1.09) 
PFHxS 0.04 (-0.31, 0.38) -0.15 (-0.70, 0.41) 0.15 (-0.29, 0.59) 
PFNA 0.20 (-0.38, 0.79) 0.26 (-0.65, 1.18) 0.29 (-0.49, 1.07) 
Waist-to-hip circumference ratiod    
PFOS 0.35 (-0.23, 0.93) 0.37 (-0.52, 1.27) 0.23 (-0.50, 0.97) 
PFOA -0.31 (-0.91, 0.30) -0.49 (-1.61, 0.63) -0.11 (-0.79, 0.56) 
PFHxS 0.13 (-0.15, 0.40) -0.01 (-0.51, 0.49) 0.19 (-0.10, 0.49) 
PFNA 0.27 (-0.20, 0.73) 0.40 (-0.40, 1.21) 0.21 (-0.31, 0.74) 
Subscapular-to-triceps skinfold 
thickness ratiod    
PFOS -0.25 (-2.00, 1.49) 0.48 (-1.90, 2.86) -1.14 (-3.73, 1.45) 
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PFOA 0.23 (-1.62, 2.07) -1.25 (-4.25, 1.74) 1.27 (-1.16, 3.69) 
PFHxS 0.52 (-0.30, 1.34) -0.69 (-2.00, 0.61) 1.43 (0.36, 2.50) 
PFNA 1.64 (0.25, 3.04) 1.69 (-0.47, 3.84) 1.83 (-0.05, 3.71) 
DXA trunk fat mass index (kg/m2)    
PFOS 0.01 (-0.08, 0.10) 0.01 (-0.11, 0.12) 0.01 (-0.12, 0.14) 
PFOA 0.05 (-0.04, 0.14) 0.07 (-0.08, 0.23) 0.04 (-0.07, 0.16) 
PFHxS 0.01 (-0.03, 0.05) -0.03 (-0.09, 0.04) 0.03 (-0.02, 0.08) 
PFNA 0.01 (-0.06, 0.09) -0.01 (-0.11, 0.09) 0.04 (-0.08, 0.16) 
BMI, body mass index; DXA, dual X-ray absorptiometry; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane 
sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate. 
aEffect estimates represent the mean change in the outcome for a change in PFAS concentrations from the 25th to the 75th 
percentile (or interquartile range). 
bModels adjusted for all four PFAS, maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of sample 
collection, household income, child sex and age at outcome assessment. 
cChildren with data on BMI and BMI z-score: 871 (450 boys and 421 girls); sum of subscapular and triceps skinfold thickness 
and subscapular-to-triceps skinfold thickness ratio: 873 (451 boys and 422 girls); DXA total fat mass, total fat-free mass, and 
trunk fat mass indexes: 700 (356 boys and 344 girls); waist circumference: 873 (453 boys and 420 girls); and waist-to-hip 
circumference ratio: 861 (448 boys and 413 girls). 






Table S6. Associations of prenatal plasma PFAS concentrations with overall and central adiposity measurements in early childhood among all children and stratified by 
child sex, after adjusting for maternal GFR and albumin levels during pregnancy.a,b 
 Additionally adjusted for GFRc  Additionally adjusted for albumind 
All children  Boys Girls 
pint
 All children  Boys  Girls  
pint β (95% CI)  β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Overall adiposity     
BMI (kg/m2)    
PFOS 0.04 (-0.05, 0.13)  0.01 (-0.12, 0.15)  0.05 (-0.07, 0.18)  0.57  0.03 (-0.06, 0.12)  0.02 (-0.11, 0.15)  0.02 (-0.10, 0.15)  0.57 
PFOA 0.09 (-0.02, 0.19)  0.08 (-0.10, 0.25)  0.09 (-0.05, 0.23)  0.83  0.08 (-0.03, 0.19)  0.08 (-0.09, 0.26)  0.06 (-0.08, 0.20)  0.81 
PFHxS 0.01 (-0.05, 0.06)  0.00 (-0.08, 0.08)  0.01 (-0.06, 0.08)  0.94  0.01 (-0.05, 0.06)  0.00 (-0.08, 0.08)  0.00 (-0.07, 0.08)  0.95 
PFNA 0.03 (-0.07, 0.12)  -0.06 (-0.19, 0.08)  0.09 (-0.04, 0.22)  0.20  0.02 (-0.07, 0.11)  -0.05 (-0.18, 0.08)  0.06 (-0.07, 0.19)  0.20 
BMI z-score                
PFOS 0.03 (-0.03, 0.09)  0.01 (-0.08, 0.10)  0.05 (-0.03, 0.13)  0.50  0.03 (-0.03, 0.09)  0.02 (-0.08, 0.11)  0.03 (-0.05, 0.12)  0.51 
PFOA 0.05 (-0.02, 0.12)  0.02 (-0.10, 0.15)  0.07 (-0.02, 0.16)  0.63  0.05 (-0.03, 0.12)  0.03 (-0.09, 0.15)  0.05 (-0.04, 0.14)  0.61 
PFHxS 0.01 (-0.03, 0.05)  0.01 (-0.05, 0.07)  0.01 (-0.04, 0.06)  0.86  0.01 (-0.03, 0.04)  0.01 (-0.05, 0.07)  0.00 (-0.04, 0.05)  0.85 
PFNA 0.02 (-0.05, 0.08)  -0.04 (-0.13, 0.06)  0.06 (-0.03, 0.15)  0.22  0.01 (-0.05, 0.08)  -0.03 (-0.13, 0.06)  0.04 (-0.05, 0.13)  0.21 
Sum of subscapular 
and triceps skinfold 
thickness (mm)       







PFOS -0.08 (-0.34, 0.18)  -0.16 (-0.54, 0.22)  0.01 (-0.35, 0.37)  0.48  -0.11 (-0.37, 0.14)  -0.16 (-0.54, 0.21)  -0.10 (-0.46, 0.27)  0.45 
PFOA 0.21 (-0.10, 0.52)  0.43 (-0.07, 0.93)  0.10 (-0.30, 0.51)  0.47  0.18 (-0.13, 0.49)  0.42 (-0.07, 0.92)  0.00 (-0.41, 0.40)  0.54 
PFHxS 0.17 (0.01, 0.32)  0.15 (-0.09, 0.39)  0.19 (-0.02, 0.39)  0.80  0.16 (0.00, 0.31)  0.15 (-0.09, 0.38)  0.17 (-0.04, 0.37)  0.75 
PFNA 0.01 (-0.26, 0.28)  -0.25 (-0.63, 0.14)  0.24 (-0.14, 0.61)  0.18  -0.03 (-0.29, 0.24)  -0.25 (-0.63, 0.14)  0.13 (-0.25, 0.52)  0.15 
                
Central adiposity              
Waist circumference 











PFOS 0.04 (-0.18, 0.26)  -0.06 (-0.40, 0.28)  0.11 (-0.19, 0.41)  0.57  0.05 (-0.17, 0.27)  -0.02 (-0.35, 0.31)  0.08 (-0.22, 0.38)  0.61 
PFOA 0.30 (0.03, 0.56)  0.47 (0.02, 0.91)  0.17 (-0.16, 0.50)  0.25  0.31 (0.05, 0.57)  0.51 (0.07, 0.95)  0.14 (-0.20, 0.47)  0.24 
PFHxS 0.03 (-0.11, 0.16)  0.00 (-0.21, 0.21)  0.04 (-0.13, 0.22)  0.89  0.03 (-0.10, 0.16)  0.01 (-0.20, 0.22)  0.04 (-0.13, 0.21)  0.93 
PFNA -0.02 (-0.25, 0.21)  -0.22 (-0.56, 0.12)  0.14 (-0.16, 0.45)  0.35  -0.01 (-0.24, 0.22)  -0.17 (-0.51, 0.17)  0.11 (-0.20, 0.42)  0.37 
Waist-to-hip 












PFOS -0.01 (-0.36, 0.34)  -0.18 (-0.72, 0.37)  0.13 (-0.32, 0.58)  0.66  0.03 (-0.32, 0.38)  -0.13 (-0.67, 0.41)  0.12 (-0.33, 0.58)  0.66 
PFOA 0.17 (-0.25, 0.59)  0.49 (-0.23, 1.21)  -0.02 (-0.52, 0.48)  0.13  0.21 (-0.21, 0.62)  0.54 (-0.16, 1.25)  -0.02 (-0.52, 0.48)  0.12 
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PFHxS -0.01 (-0.22, 0.20)  0.08 (-0.26, 0.42)  -0.07 (-0.32, 0.19)  0.44  0.00 (-0.21, 0.21)  0.09 (-0.25, 0.43)  -0.07 (-0.33, 0.19)  0.44 
PFNA 0.18 (-0.18, 0.54)  0.34 (-0.21, 0.89)  0.11 (-0.35, 0.58)  0.46  0.22 (-0.14, 0.58)  0.39 (-0.15, 0.94)  0.11 (-0.36, 0.58)  0.43 
Subscapular-to-
triceps skinfold 
thickness ratioe     
 
 







PFOS 0.12 (-0.85, 1.08)  0.47 (-0.87, 1.80)  -0.24 (-1.64, 1.16)  0.69  0.21 (-0.74, 1.17)  0.54 (-0.77, 1.86)  -0.16 (-1.59, 1.27)  0.59 
PFOA 0.40 (-0.75, 1.55)  0.03 (-1.73, 1.78)  0.61 (-0.96, 2.18)  0.38  0.51 (-0.63, 1.66)  0.13 (-1.61, 1.87)  0.78 (-0.79, 2.36)  0.44 
PFHxS -0.17 (-0.74, 0.41)  -0.39 (-1.22, 0.44)  -0.02 (-0.83, 0.79)  0.36  -0.13 (-0.71, 0.44)  -0.34 (-1.17, 0.48)  -0.01 (-0.82, 0.80)  0.44 
PFNA 0.36 (-0.63, 1.35)  0.43 (-0.93, 1.78)  0.19 (-1.28, 1.65)  0.93  0.46 (-0.53, 1.45)   0.50 (-0.85, 1.85)  0.33 (-1.16, 1.82)  0.86 
BMI, body mass index; GFR, glomerular filtration rate; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane 
sulfonate. 
aEffect estimates represent the mean change in the outcome for a change in PFAS concentrations from the 25th to the 75th percentile (or interquartile range). 
bChildren with data on BMI and BMI z-score: 988 (522 boys and 466 girls); sum of subscapular and triceps skinfold thickness and subscapular-to-triceps skinfold thickness ratio: 964 (509 boys and 455 girls); waist 
circumference: 992 (521 boys and 471 girls); and waist-to-hip circumference ratio: 987 (519 boys and 468 girls). 
cModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, child sex and age at outcome assessment, and maternal GFR during pregnancy. 
dModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, child sex and age at outcome assessment, and maternal albumin concentrations 
during pregnancy.  






Table S7. Associations of prenatal plasma PFAS concentrations with overall and central adiposity measurements in mid-childhood among all children and stratified by child 
sex, after adjusting for maternal GFR and albumin levels during pregnancy.a,b 
 Additionally adjusted for GFRc  Additionally adjusted for albumind 
All children  Boys Girls 
pint 
 All children  Boys  Girls  
pint β (95% CI)  β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Overall adiposity     
BMI (kg/m2)    
PFOS 0.17 (-0.03, 0.38)  -0.03 (-0.33, 0.28) 0.30 (0.04, 0.57)  0.23  0.12 (-0.09, 0.32)  -0.03 (-0.33, 0.27)  0.22 (-0.06, 0.50)  0.27 
PFOA 0.14 (-0.09, 0.37)  -0.07 (-0.46, 0.33) 0.24 (-0.03, 0.52)  0.21  0.09 (-0.14, 0.32)  -0.09 (-0.48, 0.31)  0.17 (-0.10, 0.44)  0.18 
PFHxS 0.05 (-0.08, 0.17)  -0.07 (-0.27, 0.13) 0.11 (-0.04, 0.26)  0.15  0.03 (-0.09, 0.16)  -0.07 (-0.27, 0.13)  0.09 (-0.07, 0.24)  0.15 
PFNA 0.18 (-0.01, 0.37)  0.00 (-0.31, 0.30) 0.33 (0.08, 0.58)  0.32  0.13 (-0.06, 0.33)  -0.02 (-0.33, 0.29)  0.27 (0.02, 0.52)  0.28 
BMI z-score               
PFOS 0.08 (0.01, 0.14)  0.04 (-0.06, 0.14) 0.10 (0.00, 0.19)  0.52  0.05 (-0.02, 0.12)  0.03 (-0.07, 0.13)  0.06 (-0.04, 0.16)  0.58 
PFOA 0.05 (-0.03, 0.13)  -0.04 (-0.17, 0.08) 0.10 (0.00, 0.20)  0.07  0.03 (-0.05, 0.10)  -0.05 (-0.18, 0.08)  0.07 (-0.03, 0.16)  0.06 
PFHxS 0.01 (-0.03, 0.05)  -0.01 (-0.07, 0.06) 0.02 (-0.04, 0.07)  0.55  0.00 (-0.04, 0.04)  -0.01 (-0.07, 0.06)  0.01 (-0.05, 0.06)  0.54 
PFNA 0.05 (-0.01, 0.12)  0.02 (-0.08, 0.12) 0.08 (-0.01, 0.17)  0.70  0.03 (-0.04, 0.09)  0.01 (-0.09, 0.11)  0.05 (-0.04, 0.14)  0.60 
Sum of subscapular 
and triceps skinfold 
thickness (mm)               
PFOS 0.55 (-0.09, 1.19)  0.17 (-0.73, 1.07) 0.81 (-0.12, 1.74)  0.41  0.33 (-0.32, 0.99)  -0.05 (-0.94, 0.83)  0.68 (-0.29, 1.65)  0.45 
PFOA 0.57 (-0.15, 1.29)  -0.02 (-1.18, 1.14) 0.85 (-0.09, 1.80)  0.32  0.36 (-0.37, 1.08)  -0.33 (-1.50, 0.83)  0.71 (-0.24, 1.66)  0.28 
PFHxS 0.27 (-0.12, 0.67)  -0.20 (-0.79, 0.39) 0.58 (0.05, 1.12)  0.07  0.21 (-0.18, 0.61)  -0.28 (-0.87, 0.30)  0.55 (0.01, 1.08)  0.06 
PFNA 0.70 (0.08, 1.31)  0.22 (-0.68, 1.11) 1.09 (0.23, 1.95)  0.44  0.50 (-0.12, 1.12)  -0.07 (-0.97, 0.84)  0.97 (0.10, 1.84)  0.37 
DXA total fat mass 
index (kg/m2)               
PFOS 0.14 (-0.01, 0.28)  0.04 (-0.16, 0.25) 0.19 (0.00, 0.39)  0.41  0.09 (-0.06, 0.23)  0.01 (-0.19, 0.21)  0.14 (-0.06, 0.35)  0.45 
PFOA 0.16 (0.00, 0.32)  0.08 (-0.19, 0.36) 0.19 (0.00, 0.39)  0.35  0.11 (-0.05, 0.27)  0.04 (-0.24, 0.32)  0.15 (-0.04, 0.34)  0.28 
PFHxS 0.05 (-0.03, 0.13)  -0.04 (-0.17, 0.10) 0.09 (-0.02, 0.20)  0.11  0.04 (-0.05, 0.12)  -0.05 (-0.18, 0.08)  0.08 (-0.03, 0.19)  0.10 
PFNA 0.10 (-0.05, 0.25)  -0.02 (-0.21, 0.18) 0.24 (0.01, 0.47)  0.27  0.05 (-0.10, 0.20)  -0.05 (-0.25, 0.15)  0.18 (-0.06, 0.41)  0.29 
DXA total fat-free 
mass index (kg/m2)               
PFOS 0.08 (-0.01, 0.18)  0.03 (-0.11, 0.18) 0.12 (-0.02, 0.25)  0.64  0.09 (-0.01, 0.19)  0.07 (-0.07, 0.21)  0.08 (-0.06, 0.23)  0.61 
PFOA 0.06 (-0.05, 0.17)  0.02 (-0.18, 0.21) 0.08 (-0.05, 0.22)  0.60  0.06 (-0.05, 0.17)  0.07 (-0.12, 0.27)  0.06 (-0.08, 0.19)  0.60 
PFHxS 0.00 (-0.05, 0.06)  -0.03 (-0.12, 0.06) 0.02 (-0.06, 0.09)  0.52  0.00 (-0.05, 0.06)  -0.02 (-0.11, 0.08)  0.01 (-0.07, 0.08)  0.52 
PFNA 0.08 (-0.02, 0.19)  0.07 (-0.06, 0.21) 0.07 (-0.10, 0.23)  0.75  0.08 (-0.02, 0.19)  0.12 (-0.02, 0.25)  0.03 (-0.14, 0.19)  0.75 
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Central adiposity              
Waist circumference 
(cm)                
PFOS 0.41 (-0.12, 0.95)  -0.01 (-0.79, 0.77) 0.69 (-0.06, 1.43)  0.35  0.21 (-0.33, 0.76)  -0.08 (-0.85, 0.69)  0.42 (-0.36, 1.20)  0.41 
PFOA 0.27 (-0.33, 0.88)  -0.32 (-1.33, 0.68) 0.57 (-0.18, 1.32)  0.20  0.08 (-0.53, 0.68)  -0.45 (-1.46, 0.56)  0.34 (-0.41, 1.09)  0.17 
PFHxS 0.12 (-0.20, 0.45)  -0.15 (-0.66, 0.36) 0.26 (-0.16, 0.69)  0.24  0.07 (-0.26, 0.39)  -0.18 (-0.69, 0.33)  0.20 (-0.22, 0.63)  0.23 
PFNA 0.38 (-0.13, 0.89)  0.13 (-0.65, 0.90) 0.59 (-0.09, 1.27)  0.83  0.20 (-0.32, 0.71)  0.01 (-0.77, 0.80)  0.39 (-0.30, 1.08)  0.72 
Waist-to-hip 
circumference ratioe               
PFOS 0.41 (-0.02, 0.83)  0.36 (-0.34, 1.05) 0.40 (-0.11, 0.90)  0.66  0.39 (-0.04, 0.82)  0.39 (-0.29, 1.08)  0.31 (-0.21, 0.84)  0.70 
PFOA 0.14 (-0.34, 0.61)  0.00 (-0.89, 0.90) 0.23 (-0.28, 0.74)  0.78  0.11 (-0.37, 0.59)  0.07 (-0.83, 0.97)  0.15 (-0.36, 0.66)  0.80 
PFHxS 0.19 (-0.07, 0.45)  0.06 (-0.41, 0.52) 0.25 (-0.03, 0.54)  0.75  0.19 (-0.07, 0.45)  0.07 (-0.39, 0.53)  0.23 (-0.06, 0.52)  0.74 
PFNA 0.40 (-0.01, 0.80)  0.42 (-0.26, 1.11) 0.38 (-0.08, 0.84)  0.65  0.38 (-0.03, 0.79)  0.50 (-0.20, 1.20)  0.31 (-0.16, 0.77)  0.65 
Subscapular-to-
triceps skinfold 
thickness ratioe               
PFOS 0.85 (-0.44, 2.13)  0.40 (-1.45, 2.25) 1.14 (-0.67, 2.95)  0.39  1.00 (-0.31, 2.31)  0.32 (-1.51, 2.14)  1.69 (-0.20, 3.58)  0.40 
PFOA 0.89 (-0.55, 2.34)  -0.41 (-2.80, 1.98) 1.45 (-0.38, 3.29)  0.08  1.04 (-0.42, 2.50)  -0.59 (-2.99, 1.82)  1.86 (0.01, 3.70)  0.08 
PFHxS 0.71 (-0.08, 1.49)  -0.52 (-1.73, 0.70) 1.57 (0.54, 2.60)  <0.01  0.74 (-0.04, 1.53)  -0.55 (-1.76, 0.66)  1.68 (0.64, 2.72)  <0.01 
PFNA 1.69 (0.47, 2.92)  1.23 (-0.61, 3.07) 2.02 (0.35, 3.69)  0.42  1.85 (0.61, 3.08)  1.10 (-0.76, 2.96)  2.40 (0.72, 4.09)  0.45 
DXA trunk fat mass 
index (kg/m2)               
PFOS 0.05 (-0.01, 0.12)  0.02 (-0.07, 0.11) 0.07 (-0.02, 0.16)  0.58  0.04 (-0.03, 0.10)  0.01 (-0.08, 0.10)  0.06 (-0.04, 0.15)  0.62 
PFOA 0.07 (0.00, 0.14)  0.06 (-0.07, 0.18) 0.08 (-0.01, 0.17)  0.59  0.06 (-0.01, 0.13)  0.05 (-0.08, 0.17)  0.07 (-0.02, 0.15)  0.51 
PFHxS 0.02 (-0.02, 0.06)  -0.01 (-0.07, 0.04) 0.04 (-0.01, 0.09)  0.14  0.02 (-0.02, 0.05)  -0.02 (-0.07, 0.04)  0.04 (-0.01, 0.08)  0.13 
PFNA 0.05 (-0.02, 0.11)  0.01 (-0.08, 0.10) 0.08 (-0.02, 0.19)  0.61  0.03 (-0.04, 0.10)  0.00 (-0.09, 0.09)  0.06 (-0.04, 0.17)  0.63 
BMI, body mass index; DXA, dual X-ray absorptiometry; GFR, glomerular filtration rate; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, 
perfluorooctanoate; PFOS, perfluorooctane sulfonate. 
aEffect estimates represent the mean change in the outcome for a change in PFAS concentrations from the 25th to the 75th percentile (or interquartile range). 
bChildren with data on BMI and BMI z-score: 871 (450 boys and 421 girls); sum of subscapular and triceps skinfold thickness and subscapular-to-triceps skinfold thickness ratio: 873 (451 boys and 422 girls); DXA 
total fat mass, total fat-free mass, and trunk fat mass indexes: 700 (356 boys and 344 girls); waist circumference: 873 (453 boys and 420 girls); and waist-to-hip circumference ratio: 861 (448 boys and 413 girls). 
cModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, child sex and age at outcome assessment, and maternal GFR during pregnancy. 
dModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, child sex and age at outcome assessment, and maternal albumin concentrations 
during pregnancy.  




Table S8. Longitudinal associations of prenatal plasma PFAS concentrations with overall and central adiposity 
measurements collected in early and mid-childhood, estimated using linear regression models with generalized 
estimation equations (GEE).a,b 
  
All childrenc   Boysc   Girlsc   
pint β (95% CI)   β (95% CI)   β (95% CI)   
Overall adiposity 
BMI (kg/m2) 
PFOS 0.10 (-0.02, 0.22)  0.05 (-0.13, 0.23)  0.15 (-0.01, 0.31)  0.35 
PFOA 0.11 (-0.04, -0.25)  0.04 (-0.20, 0.27)  0.13 (-0.04, 0.30)  0.39 
PFHxS 0.02 (-0.06, 0.09)  -0.02 (-0.14, 0.09)  0.04 (-0.05, 0.13)  0.41 
PFNA 0.10 (-0.02, 0.22)  -0.03 (-0.21, 0.15)  0.20 (0.04, 0.36)  0.16 
BMI z-score        
PFOS 0.04 (-0.01, 0.09)  0.02 (-0.05, 0.10)  0.05 (-0.02, 0.12)  0.52 
PFOA 0.04 (-0.02, 0.11)  0.00 (-0.11, 0.10)  0.07 (-0.01, 0.15)  0.19 
PFHxS 0.01 (-0.03, 0.04)  0.00 (-0.05, 0.05)  0.01 (-0.03, 0.05)  0.80 
PFNA 0.03 (-0.03, 0.08)  -0.02 (-0.10, 0.07)  0.06 (-0.01, 0.13)  0.25 
Sum of subscapular and triceps 
skinfold thickness (mm)        
PFOS 0.26 (-0.10, 0.62)  0.13 (-0.39, 0.65)  0.38 (-0.13, 0.89)  0.45 
PFOA 0.37 (-0.06, 0.80)  0.25 (-0.42, 0.93)  0.40 (-0.15, 0.95)  0.78 
PFHxS 0.19 (-0.03, 0.42)  0.04 (-0.29, 0.37)  0.30 (0.01, 0.60)  0.31 
PFNA 0.37 (0.00, 0.73)  0.00 (-0.53, 0.53)  0.66 (0.15, 1.17)  0.27 
       
Central adiposity        
Waist circumference (cm)        
PFOS 0.23 (-0.08, 0.54)  0.07 (-0.39, 0.52)  0.35 (-0.05, 0.76)  0.39 
PFOA 0.28 (-0.08, 0.65)  0.19 (-0.42, 0.79)  0.29 (-0.15, 0.73)  0.74 
PFHxS 0.05 (-0.14, 0.24)  -0.04 (-0.33, 0.26)  0.10 (-0.13, 0.40)  0.55 
PFNA 0.19 (-0.12, 0.51)  -0.02 (-0.49, 0.45)  0.37 (-0.04, 0.77)  0.56 
Waist-to-hip circumference ratio        
PFOS 0.20 (-0.08, 0.48)  0.09 (-0.35, 0.52)  0.28 (-0.07, 0.63)  0.96 
PFOA 0.17 (-0.16, 0.50)  0.30 (-0.28, 0.87)  0.09 (-0.29, 0.46)  0.22 
PFHxS 0.07 (-0.10, 0.24)  0.08 (-0.21, 0.36)  0.06 (-0.15, 0.26)  0.73 
PFNA 0.30 (0.02, 0.58)  0.40 (-0.05, 0.84)  0.27 (-0.08, 0.61)  0.46 
Subscapular-to-triceps skinfold 
thickness ratio        
PFOS 0.59 (-0.26, 1.43)  0.61 (-0.56, 1.78)  0.53 (-0.69, 1.75)  0.95 
PFOA 0.66 (-0.33, 1.66)  -0.01 (-1.54, 1.52)  1.07 (-0.24, 2.39)  0.14 
PFHxS 0.20 (-0.32, 0.71)  -0.40 (-1.16, 0.35)  0.65 (-0.06, 1.35)  0.02 
PFNA 1.15 (0.29, 2.00)  0.88 (-0.31, 2.08)  1.38 (0.17, 2.60)  0.69 
BMI, body mass index; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, 
perfluorooctanoate; PFOS, perfluorooctane sulfonate. 
aEffect estimates represent the mean change in the outcome for a change in PFAS concentrations from the 25th to the 75th percentile (or 
interquartile range). 
bModels adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI, timing of blood draw, household income, child sex 
and age at outcome assessment. 
cChildren with repeated data on BMI and BMI z-score: 1,100 (588 boys and 512 girls); with repeated data on sum of subscapular and triceps 
skinfold thickness and subscapular-to-triceps skinfold thickness ratio: 1,095 (581 boys and 514 girls); with repeated data on waist 
circumference: 1,101 (586 boys and 515 girls); and with repeated data on waist-to-hip circumference ratio: 1,097 (585 boys and 512 girls). 
 
 
